Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
Global Opioids Drug main players are Purdue Pharma, Teva, Pfizer, Hikma, etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share nearly 70%.
The global Opioids Drug market was valued at US$ 10240 million in 2020 and is expected to reach US$ 9016.6 million by the end of 2029, growing at a CAGR of -1.8% during 2021-2029.
This report focuses on Opioids Drug volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Opioids Drug market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Opioids Drug Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2029. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Oxycodone
Hydromorphone
Codeine
Fentanyl
Segment by Application
Pain Relief
Anesthesia
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
J&J
Endo
Pfizer
INSYS
Mylan
Hikma
Egalet
1 Opioids Drug Market Overview
1.1 Product Overview and Scope of Opioids Drug
1.2 Opioids Drug Segment by Type
1.2.1 Global Opioids Drug Sales Growth Rate Comparison by Type (2021-2029)
1.2.2 Oxycodone
1.2.3 Hydromorphone
1.2.4 Codeine
1.2.5 Fentanyl
1.3 Opioids Drug Segment by Application
1.3.1 Global Opioids Drug Sales Comparison by Application: (2021-2029)
1.3.2 Pain Relief
1.3.3 Anesthesia
1.3.4 Others
1.4 Global Opioids Drug Market Size Estimates and Forecasts
1.4.1 Global Opioids Drug Revenue 2016-2029
1.4.2 Global Opioids Drug Sales 2016-2029
1.4.3 Opioids Drug Market Size by Region: 2016 Versus 2021 Versus 2029
2 Opioids Drug Market Competition by Manufacturers
2.1 Global Opioids Drug Sales Market Share by Manufacturers (2016-2021)
2.2 Global Opioids Drug Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Opioids Drug Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Opioids Drug Manufacturing Sites, Area Served, Product Type
2.5 Opioids Drug Market Competitive Situation and Trends
2.5.1 Opioids Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Opioids Drug Players Market Share by Revenue
2.5.3 Global Opioids Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Opioids Drug Retrospective Market Scenario by Region
3.1 Global Opioids Drug Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Opioids Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Opioids Drug Market Facts & Figures by Country
3.3.1 North America Opioids Drug Sales by Country
3.3.2 North America Opioids Drug Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Opioids Drug Market Facts & Figures by Country
3.4.1 Europe Opioids Drug Sales by Country
3.4.2 Europe Opioids Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Opioids Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Opioids Drug Sales by Region
3.5.2 Asia Pacific Opioids Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Opioids Drug Market Facts & Figures by Country
3.6.1 Latin America Opioids Drug Sales by Country
3.6.2 Latin America Opioids Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Opioids Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Opioids Drug Sales by Country
3.7.2 Middle East and Africa Opioids Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Opioids Drug Historic Market Analysis by Type
4.1 Global Opioids Drug Sales Market Share by Type (2016-2021)
4.2 Global Opioids Drug Revenue Market Share by Type (2016-2021)
4.3 Global Opioids Drug Price by Type (2016-2021)
5 Global Opioids Drug Historic Market Analysis by Application
5.1 Global Opioids Drug Sales Market Share by Application (2016-2021)
5.2 Global Opioids Drug Revenue Market Share by Application (2016-2021)
5.3 Global Opioids Drug Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Teva Opioids Drug Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 Purdue Pharma
6.2.1 Purdue Pharma Corporation Information
6.2.2 Purdue Pharma Description and Business Overview
6.2.3 Purdue Pharma Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Purdue Pharma Opioids Drug Product Portfolio
6.2.5 Purdue Pharma Recent Developments/Updates
6.3 Mallinckrodt
6.3.1 Mallinckrodt Corporation Information
6.3.2 Mallinckrodt Description and Business Overview
6.3.3 Mallinckrodt Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Mallinckrodt Opioids Drug Product Portfolio
6.3.5 Mallinckrodt Recent Developments/Updates
6.4 Amneal Pharma
6.4.1 Amneal Pharma Corporation Information
6.4.2 Amneal Pharma Description and Business Overview
6.4.3 Amneal Pharma Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Amneal Pharma Opioids Drug Product Portfolio
6.4.5 Amneal Pharma Recent Developments/Updates
6.5 Collegium
6.5.1 Collegium Corporation Information
6.5.2 Collegium Description and Business Overview
6.5.3 Collegium Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Collegium Opioids Drug Product Portfolio
6.5.5 Collegium Recent Developments/Updates
6.6 J&J
6.6.1 J&J Corporation Information
6.6.2 J&J Description and Business Overview
6.6.3 J&J Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
6.6.4 J&J Opioids Drug Product Portfolio
6.6.5 J&J Recent Developments/Updates
6.7 Endo
6.6.1 Endo Corporation Information
6.6.2 Endo Description and Business Overview
6.6.3 Endo Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Endo Opioids Drug Product Portfolio
6.7.5 Endo Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Pfizer Opioids Drug Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 INSYS
6.9.1 INSYS Corporation Information
6.9.2 INSYS Description and Business Overview
6.9.3 INSYS Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
6.9.4 INSYS Opioids Drug Product Portfolio
6.9.5 INSYS Recent Developments/Updates
6.10 Mylan
6.10.1 Mylan Corporation Information
6.10.2 Mylan Description and Business Overview
6.10.3 Mylan Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Mylan Opioids Drug Product Portfolio
6.10.5 Mylan Recent Developments/Updates
6.11 Hikma
6.11.1 Hikma Corporation Information
6.11.2 Hikma Opioids Drug Description and Business Overview
6.11.3 Hikma Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Hikma Opioids Drug Product Portfolio
6.11.5 Hikma Recent Developments/Updates
6.12 Egalet
6.12.1 Egalet Corporation Information
6.12.2 Egalet Opioids Drug Description and Business Overview
6.12.3 Egalet Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Egalet Opioids Drug Product Portfolio
6.12.5 Egalet Recent Developments/Updates
7 Opioids Drug Manufacturing Cost Analysis
7.1 Opioids Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Opioids Drug
7.4 Opioids Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Opioids Drug Distributors List
8.3 Opioids Drug Customers
9 Opioids Drug Market Dynamics
9.1 Opioids Drug Industry Trends
9.2 Opioids Drug Growth Drivers
9.3 Opioids Drug Market Challenges
9.4 Opioids Drug Market Restraints
10 Global Market Forecast
10.1 Opioids Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Opioids Drug by Type (2022-2029)
10.1.2 Global Forecasted Revenue of Opioids Drug by Type (2022-2029)
10.2 Opioids Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Opioids Drug by Application (2022-2029)
10.2.2 Global Forecasted Revenue of Opioids Drug by Application (2022-2029)
10.3 Opioids Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Opioids Drug by Region (2022-2029)
10.3.2 Global Forecasted Revenue of Opioids Drug by Region (2022-2029)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Opioids Drug Sales (M Units) Growth Rate Comparison by Type (2021-2029)
Table 2. Global Opioids Drug Sales (M Units) Comparison by Application (2021-2029)
Table 3. Global Opioids Drug Market Size by Region (US$ Million) (2016 VS 2021 VS 2029)
Table 4. Key Manufacturers Opioids Drug Covered in This Study
Table 5. Global Opioids Drug Sales (M Units) of Key Manufacturers (2016-2021)
Table 6. Global Opioids Drug Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Opioids Drug Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Opioids Drug Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Opioids Drug Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Opioids Drug Manufacturing Sites and Area Served
Table 11. Manufacturers Opioids Drug Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Opioids Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioids Drug as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Opioids Drug Sales by Region (2016-2021) & (M Units)
Table 16. Global Opioids Drug Sales Market Share by Region (2016-2021)
Table 17. Global Opioids Drug Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Opioids Drug Sales by Country (2016-2021) & (M Units)
Table 19. North America Opioids Drug Sales Market Share by Country (2016-2021)
Table 20. North America Opioids Drug Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Opioids Drug Revenue Market Share by Country (2016-2021)
Table 22. Europe Opioids Drug Sales by Country (2016-2021) & (M Units)
Table 23. Europe Opioids Drug Sales Market Share by Country (2016-2021)
Table 24. Europe Opioids Drug Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Opioids Drug Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Opioids Drug Sales by Region (2016-2021) & (M Units)
Table 27. Asia Pacific Opioids Drug Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Opioids Drug Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Opioids Drug Revenue Market Share by Region (2016-2021)
Table 30. Latin America Opioids Drug Sales by Country (2016-2021) & (M Units)
Table 31. Latin America Opioids Drug Sales Market Share by Country (2016-2021)
Table 32. Latin America Opioids Drug Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Opioids Drug Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Opioids Drug Sales by Country (2016-2021) & (M Units)
Table 35. Middle East and Africa Opioids Drug Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Opioids Drug Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Opioids Drug Revenue Market Share by Country (2016-2021)
Table 38. Global Opioids Drug Sales (M Units) by Type (2016-2021)
Table 39. Global Opioids Drug Sales Market Share by Type (2016-2021)
Table 40. Global Opioids Drug Revenue (Million US$) by Type (2016-2021)
Table 41. Global Opioids Drug Revenue Share by Type (2016-2021)
Table 42. Global Opioids Drug Price (USD/Unit) by Type (2016-2021)
Table 43. Global Opioids Drug Sales (M Units) by Application (2016-2021)
Table 44. Global Opioids Drug Sales Market Share by Application (2016-2021)
Table 45. Global Opioids Drug Revenue (Million US$) by Application (2016-2021)
Table 46. Global Opioids Drug Revenue Share by Application (2016-2021)
Table 47. Global Opioids Drug Price (USD/Unit) by Application (2016-2021)
Table 48. Teva Corporation Information
Table 49. Teva Description and Business Overview
Table 50. Teva Opioids Drug Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Teva Opioids Drug Product
Table 52. Teva Recent Developments/Updates
Table 53. Purdue Pharma Corporation Information
Table 54. Purdue Pharma Description and Business Overview
Table 55. Purdue Pharma Opioids Drug Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Purdue Pharma Opioids Drug Product
Table 57. Purdue Pharma Recent Developments/Updates
Table 58. Mallinckrodt Corporation Information
Table 59. Mallinckrodt Description and Business Overview
Table 60. Mallinckrodt Opioids Drug Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Mallinckrodt Opioids Drug Product
Table 62. Mallinckrodt Recent Developments/Updates
Table 63. Amneal Pharma Corporation Information
Table 64. Amneal Pharma Description and Business Overview
Table 65. Amneal Pharma Opioids Drug Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Amneal Pharma Opioids Drug Product
Table 67. Amneal Pharma Recent Developments/Updates
Table 68. Collegium Corporation Information
Table 69. Collegium Description and Business Overview
Table 70. Collegium Opioids Drug Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Collegium Opioids Drug Product
Table 72. Collegium Recent Developments/Updates
Table 73. J&J Corporation Information
Table 74. J&J Description and Business Overview
Table 75. J&J Opioids Drug Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. J&J Opioids Drug Product
Table 77. J&J Recent Developments/Updates
Table 78. Endo Corporation Information
Table 79. Endo Description and Business Overview
Table 80. Endo Opioids Drug Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Endo Opioids Drug Product
Table 82. Endo Recent Developments/Updates
Table 83. Pfizer Corporation Information
Table 84. Pfizer Description and Business Overview
Table 85. Pfizer Opioids Drug Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Pfizer Opioids Drug Product
Table 87. Pfizer Recent Developments/Updates
Table 88. INSYS Corporation Information
Table 89. INSYS Description and Business Overview
Table 90. INSYS Opioids Drug Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. INSYS Opioids Drug Product
Table 92. INSYS Recent Developments/Updates
Table 93. Mylan Corporation Information
Table 94. Mylan Description and Business Overview
Table 95. Mylan Opioids Drug Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Mylan Opioids Drug Product
Table 97. Mylan Recent Developments/Updates
Table 98. Hikma Corporation Information
Table 99. Hikma Description and Business Overview
Table 100. Hikma Opioids Drug Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Hikma Opioids Drug Product
Table 102. Hikma Recent Developments/Updates
Table 103. Egalet Corporation Information
Table 104. Egalet Description and Business Overview
Table 105. Egalet Opioids Drug Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Egalet Opioids Drug Product
Table 107. Egalet Recent Developments/Updates
Table 108. Production Base and Market Concentration Rate of Raw Material
Table 109. Key Suppliers of Raw Materials
Table 110. Opioids Drug Distributors List
Table 111. Opioids Drug Customers List
Table 112. Opioids Drug Market Trends
Table 113. Opioids Drug Growth Drivers
Table 114. Opioids Drug Market Challenges
Table 115. Opioids Drug Market Restraints
Table 116. Global Opioids Drug Sales Forecast by Type (2022-2029) & (M Units)
Table 117. Global Opioids Drug Sales Market Share Forecast by Type (2022-2029)
Table 118. Global Opioids Drug Revenue Forecast by Type (2022-2029) & (US$ Million)
Table 119. Global Opioids Drug Revenue Market Share Forecast by Type (2022-2029)
Table 120. Global Opioids Drug Sales Forecast by Application (2022-2029) & (M Units)
Table 121. Global Opioids Drug Sales Market Share Forecast by Application (2022-2029)
Table 122. Global Opioids Drug Revenue Forecast by Application (2022-2029) & (US$ Million)
Table 123. Global Opioids Drug Revenue Market Share Forecast by Application (2022-2029)
Table 124. Global Opioids Drug Sales Forecast by Region (2022-2029) & (M Units)
Table 125. Global Opioids Drug Sales Market Share Forecast by Region (2022-2029)
Table 126. Global Opioids Drug Revenue Forecast by Region (2022-2029) & (US$ Million)
Table 127. Global Opioids Drug Revenue Market Share Forecast by Region (2022-2029)
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Opioids Drug
Figure 2. Global Opioids Drug Market Share by Type in 2020 & 2029
Figure 3. Oxycodone Product Picture
Figure 4. Hydromorphone Product Picture
Figure 5. Codeine Product Picture
Figure 6. Fentanyl Product Picture
Figure 7. Global Opioids Drug Market Share by Application in 2020 & 2029
Figure 8. Pain Relief
Figure 9. Anesthesia
Figure 10. Others
Figure 11. Global Opioids Drug Revenue, (US$ Million), 2016 VS 2021 VS 2029
Figure 12. Global Opioids Drug Market Size 2016-2029 (US$ Million)
Figure 13. Global Opioids Drug Sales 2016-2029 (M Units)
Figure 14. Global Opioids Drug Market Size Market Share by Region: 2016 VS 20210 VS 2029
Figure 15. Opioids Drug Sales Share by Manufacturers in 2020
Figure 16. Global Opioids Drug Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Opioids Drug Players: Market Share by Revenue in 2020
Figure 18. Opioids Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Opioids Drug Sales Market Share by Region (2016-2021)
Figure 20. Global Opioids Drug Sales Market Share by Region in 2020
Figure 21. Global Opioids Drug Revenue Market Share by Region (2016-2021)
Figure 22. Global Opioids Drug Revenue Market Share by Region in 2020
Figure 23. U.S. Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. China Taiwan Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Opioids Drug by Type (2016-2021)
Figure 46. Sales Market Share of Opioids Drug by Application (2016-2021)
Figure 47. Sales Market Share of Opioids Drug by Application in 2020
Figure 48. Revenue Share of Opioids Drug by Application (2016-2021)
Figure 49. Revenue Share of Opioids Drug by Application in 2020
Figure 50. Manufacturing Cost Structure of Opioids Drug
Figure 51. Manufacturing Process Analysis of Opioids Drug
Figure 52. Opioids Drug Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
The research methodology employed by VICResearch has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of VICResearch. VICResearch’s methodology can be divided into five stages:
Stage 1: Secondary research
The research team first works with magazines, industry trade group, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Stage 2: Primary research: interviews with trade sources
After the first stage, the research team conducts large number of face-to-face or telephone interviews with the representative companies operating in the research field. The analysts attempt to obtain a chance to talk with leading players in the field as well as with small companies. The upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers are all included in the interviews. The data gathered during the interview is then carefully checked and compared with the secondary research.
Stage 3: Analysis of the gathered data
The analysis team checks and synthesizes the data gathered during the first two stages. To validate the data, a second series of interviews can be conducted.
Stage 4: Quantitative data
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by VICResearch. The data is based on the estimates obtained during stage 3.
The research team also provides appreciation and analysis of the market and the quantitative data contained in the reports. The data is consequently unique to VICResearch.
Stage 5: Quality control
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the VICResearch’s internal quality process.
Consulting report: +86-15323335301 020-31521856
